176 related articles for article (PubMed ID: 12208726)
1. Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.
Aiello LP; George DJ; Cahill MT; Wong JS; Cavallerano J; Hannah AL; Kaelin WG
Ophthalmology; 2002 Sep; 109(9):1745-51. PubMed ID: 12208726
[TBL] [Abstract][Full Text] [Related]
2. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Girmens JF; Erginay A; Massin P; Scigalla P; Gaudric A; Richard S
Am J Ophthalmol; 2003 Jul; 136(1):194-6. PubMed ID: 12834696
[TBL] [Abstract][Full Text] [Related]
3. von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy.
Harris AL
Oncologist; 2000; 5 Suppl 1():32-6. PubMed ID: 10804089
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy for von Hippel-Lindau disease.
Madhusudan S; Deplanque G; Braybrooke JP; Cattell E; Taylor M; Price P; Tsaloumas MD; Moore N; Huson SM; Adams C; Frith P; Scigalla P; Harris AL
JAMA; 2004 Feb; 291(8):943-4. PubMed ID: 14982909
[No Abstract] [Full Text] [Related]
5. Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy.
Richard S; Croisille L; Yvart J; Casadeval N; Eschwège P; Aghakhani N; David P; Gaudric A; Scigalla P; Hermine O
Blood; 2002 May; 99(10):3851-3. PubMed ID: 11986247
[TBL] [Abstract][Full Text] [Related]
6. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
Ning S; Laird D; Cherrington JM; Knox SJ
Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease.
Meyerle CB; Dahr SS; Wetjen NM; Jirawuthiworavong GV; Butman JA; Lonser RR; Oldfield E; Rodriguez-Coleman H; Wong WT; Chew EY
Ophthalmology; 2008 Aug; 115(8):1382-9. PubMed ID: 18395800
[TBL] [Abstract][Full Text] [Related]
8. Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416.
Schuch G; de Wit M; Höltje J; Laack E; Schilling G; Hossfeld DK; Fiedler W; Scigalla P; Jacobs MS
J Clin Oncol; 2005 May; 23(15):3624-6. PubMed ID: 15908674
[No Abstract] [Full Text] [Related]
9. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.
Wong WT; Liang KJ; Hammel K; Coleman HR; Chew EY
Ophthalmology; 2008 Nov; 115(11):1957-64. PubMed ID: 18789534
[TBL] [Abstract][Full Text] [Related]
10. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal anti-VEGF therapy for capillary hemangioblastomas in von Hippel-Lindau disease].
Michels S; Messmer E; Sutter F; Kurz-Levin MM
Klin Monbl Augenheilkd; 2008 Apr; 225(4):292-4. PubMed ID: 18401796
[TBL] [Abstract][Full Text] [Related]
12. One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment.
Munk MR; Kiss C; Huf W; Sulzbacher F; Roberts P; Mittermüller TJ; Sacu S; Simader C; Schmidt-Erfurth U
Am J Ophthalmol; 2013 Oct; 156(4):633-43. PubMed ID: 23891335
[TBL] [Abstract][Full Text] [Related]
13. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
14. Pharmacia's SU5416 not effective.
Expert Rev Anticancer Ther; 2002 Feb; 2(1):5. PubMed ID: 12113066
[No Abstract] [Full Text] [Related]
15. Continuous angiogenesis inhibition in the treatment for von Hippel-Lindau-related hemangioblastomas of retina and spinal cord.
Salim DK
J Oncol Pharm Pract; 2019 Dec; 25(8):2049-2051. PubMed ID: 31694494
[TBL] [Abstract][Full Text] [Related]
16. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Migliorini D; Haller S; Merkler D; Pugliesi-Rinaldi A; Koka A; Schaller K; Leemann B; Dietrich PY
CNS Oncol; 2015; 4(6):387-92. PubMed ID: 26497655
[TBL] [Abstract][Full Text] [Related]
17. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
[TBL] [Abstract][Full Text] [Related]
18. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
[TBL] [Abstract][Full Text] [Related]
19. Complete radiological and metabolic response of metastatic renal cell carcinoma to SU5416 (semaxanib) in a patient with probable von Hippel-Lindau syndrome.
Jennens RR; Rosenthal MA; Lindeman GJ; Michael M
Urol Oncol; 2004; 22(3):193-6. PubMed ID: 15271314
[TBL] [Abstract][Full Text] [Related]
20. Intravitreous treatment of severe ocular von Hippel-Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial.
Hwang CK; Chew EY; Cukras CA; Keenan TDL; Wong WT; Linehan WM; Chittiboina P; Pacak K; Wiley HE
Clin Exp Ophthalmol; 2021 Dec; 49(9):1048-1059. PubMed ID: 34549489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
